Healthcare News - An Overview
Novo CEO pressed by Senate to cut rates of weight problems, diabetes medications CEO Lars Fruergaard Jørgensen told lawmakers the business would look at new talks with insurers concerning the list selling prices of Wegovy and copyright whenever they pledge to keep the medicines on their formularies.Sanders swiftly condemned the transfer in a state